Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 13,773 shares at $64.82 ($907K) on 2020-06-09, disclosed to the SEC on 2020-06-10.
Open-market sale of $907k TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.80 | 412 | $26K | 2.9% |
| 2 | $64.82 | 1,688 | $109K | 12.1% |
| 3 | $64.82 | 1,688 | $109K | 12.1% |
| 4 | $65.80 | 4,515 | $297K | 32.8% |
| 5 | $66.60 | 2,585 | $172K | 19.0% |
| 6 | $66.60 | 2,585 |
| $172K |
| 19.0% |
| 7 | $67.48 | 300 | $20K | 2.2% |
| Total | $65.84 avg | 13,773 | $907K | 100% |
| Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |
| TPTX | SELL | 2020-04-24 | $1.5M | — | Filing → |